等待开盘 03-26 09:30:00 美东时间
+0.610
+0.35%
Mark Cuban, billionaire entrepreneur and CEO of Costplusdrugs.com, praised TrumpRx, a prescription drug platform launched by President Donald Trump, for its efforts in reducing the cost of certain medications for patients.
03-19 19:01
U.S. RESEARCH ROUNDUP-Alnylam Pharmaceuticals, Cogent Biosciences, Summit Therapeutics March 16 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies including Alnylam Pharmaceuticals, Cogent Biosciences and Summit Therapeutics on Monday
03-16 18:00
This whale alert can help traders discover the next big trading opportunities. ...
03-11 01:35
Humana AB ( ($SE:HUM) ) has issued an announcement. Humana has agreed to acquir...
03-10 21:36
Humana ( ($HUM) ) has shared an update. On March 5, 2026, Humana entered an und...
03-10 04:52
Humana Inc. publishes 2025 annual report Humana Inc. published its 2025 annual report, highlighting progress in its shift toward becoming a consumer healthcare company built around its Medicare Advantage core and CenterWell care delivery businesses. The company reported improvements in clinical exec
03-06 22:15
Humana prices $1.0 billion junior subordinated notes due 2056 Humana Inc. priced a public offering of $1.0 billion fixed-to-fixed rate junior subordinated notes due 2056 at 100.000% of principal, with the deal expected to close March 9, 2026. The company expects net proceeds of about $986 million an
03-06 08:08
CVS taps Google Cloud to roll out AI-powered health platform March 5 (Reuters) - CVS Health CVS.N will launch an AI-enabled platform in partnership with Alphabet's GOOGL.O Google Cloud unit that will bring together data from diverse sources to help customers manage their health in real time, they sa
03-05 22:00
The Federal Reserve Bank of New York estimated on Wednesday that rising employee health insurance costs, driven by increased healthcare spending due to GLP-1 obesity drugs and other factors, dragged w...
03-05 00:58
Humana reaffirms FY 2026 EPS guidance of at least $8.89 GAAP and $9.00 adjusted Humana Inc. said it will reaffirm its full-year 2026 earnings outlook, guiding for at least $8.89 in diluted GAAP EPS and at least $9.00 in adjusted EPS. The adjusted figure reflects a $0.15 per-share addback for amortiz
03-02 20:31